Astrazeneca Sees 2022 Growth As Dividend Rises But COVID Boost Falls
Astrazeneca Sees 2022 Growth As Dividend Rises But COVID Boost Falls
Stay updated with breaking news from Executive Pascal Soriot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Astrazeneca Sees 2022 Growth As Dividend Rises But COVID Boost Falls
AstraZeneca sees 2022 growth as dividend rises but COVID boost falls
Astrazeneca Sees 2022 Growth As Dividend Rises But COVID Boost Falls
AstraZeneca raised its annual dividend for the first time in a decade on Thursday and forecast higher sales for 2022 as new drugs against cancer, kidney disease and rare conditions make up for a... | February 10, 2022
AstraZeneca forecast higher 2022 sales and raised its annual dividend for the first time in a decade on Thursday after beating fourth-quarter profit expectations, but warned the boost from its... | February 10, 2022